SARS News and Research

RSS

Early Heparin therapy improves hypoxia in COVID-19 patients

The systemic use of heparin for treating severe coronavirus disease (COVID-19) showed significant improvements in oxygen exchange and overall clinical presentation of patients, as reported by a study from Brazil available on a preprint server medRxiv.

26 Apr 2020

Misinformation on COVID-19 is tied to media usage

People who relied on conservative media or social media in the early days of the COVID-19 outbreak were more likely to be misinformed about how to prevent the virus and believe conspiracy theories about it, a study of media use and public knowledge has found.

25 Apr 2020

UCLA scientists receive awards to pursue treatments and vaccines for COVID-19

Three researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received awards to pursue treatments and vaccines for COVID-19 from the California Institute for Regenerative Medicine, the state's stem cell agency.

25 Apr 2020

New antibody test to identify individuals infected with COVID-19 virus

Several tests have been developed for detecting the genetic material of the SARS-CoV-2 coronavirus that causes COVID-19, but these generally only allow detection of the virus during acute infection.

25 Apr 2020

Research Luxembourg launches Predi-COVID study

The Research Luxembourg COVID-19 task force announces the start of "Predi-COVID", a study that aims to identify important risk factors and biomarkers associated with COVID-19 severity and long-term health consequences of the disease in Luxembourg.

24 Apr 2020

Resurgence of measles or polio outbreaks likely to happen, experts warn

Interruptions to vaccination programmes caused by the COVID-19 pandemic could result in new waves of measles or polio outbreaks, health experts warn.

24 Apr 2020

Higher blood levels of NETs linked to more severe COVID-19 infection

New research finds a connection between destructive white blood cells and a more severe disease course in patients with COVID-19.

24 Apr 2020

USask's VIDO-Intervac receives $23 million to fast-track development of COVID-19 vaccine

The University of Saskatchewan's VIDO-InterVac (Vaccine and Infectious Disease Organization-International Vaccine Centre) has been awarded $23 million to fast-track efforts to develop a COVID-19 vaccine, Prime Minister Justin Trudeau announced today.

24 Apr 2020

Indiana State Department of Health and IU collaborate to study COVID-19 spread

The Indiana State Department of Health is collaborating with the Indiana University Richard M. Fairbanks School of Public Health at IUPUI to conduct a scientific study to measure the spread of COVID-19 throughout the state.

24 Apr 2020

Combination of two fabrics can effectively filter aerosol particles in face masks

In the wake of the COVID-19 pandemic, the U.S. Centers for Disease Control and Prevention recommends that people wear masks in public.

24 Apr 2020

Siemens Healthineers to expand SARS-CoV-2 testing to include a total antibody test to aid in the COVID-19 pandemic

Siemens Healthineers announced today it is significantly expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic. Recognizing the critical need for accurate diagnostic testing to manage COVID-19, the company has developed a laboratory-based total antibody test1 to detect the presence of SARS-CoV-2 antibodies in blood.

From Siemens Healthineers Point of Care Diagnostics 24 Apr 2020

Goblet cells in the human nasal passage may play key role in enabling COVID-19 infections

Two significant international studies involving hundreds of scientists, including a human geneticist at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest that specific cells in the human nasal passage shaped like a champagne glass, known as goblet cells, may play a significant role in enabling COVID-19 infections.

24 Apr 2020

Researchers report promising Phase 1 results for first oral polio vaccine in 50 years

Before being halted due to the COVID-19 pandemic, a relentless vaccination campaign had nearly succeeded in eradicating polio from the world.

24 Apr 2020

Biosero and Scripps Research Institute offer automated lab screening for COVID-19 drug therapy candidates

Biosero has designed and implemented an automated lab workflow for Scripps Research Institute so researchers can accelerate the screening of COVID-19 drug therapy candidates.

24 Apr 2020

Scientists are developing synthetic COVID-19 antibody to treat sick patients

A team of researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with GenScript, is developing a synthetic antibody to SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). This antibody is intended to block the virus from entering human lung cells, and would be another potential treatment option for COVID-19.

24 Apr 2020

NEC leverages its AI prediction platforms to design blueprints for SARS-CoV-2 vaccines

NEC Corporation today announced analysis results from efforts using AI prediction platforms to design blueprints for SARS-CoV-2 vaccines that can drive potent T-cell responses in the majority of the global population.

24 Apr 2020

AEM and Wiley offer full access to facilitate rapid dissemination of COVID-19 findings

To facilitate the rapid dissemination of COVID-19 findings, Academic Emergency Medicine (AEM) journal, in collaboration with Wiley Publishing, is fast-tracking submissions related to COVID-19 and making the latest, most relevant research available in an easy-to-navigate, freely accessible online collection of accepted and citable articles.

24 Apr 2020

UM researchers awarded $2.5 million to develop COVID-19 vaccine candidate

Researchers in the Center for Translational Medicine at the University of Montana have been awarded $2.5 million in funding from the National Institutes of Health to identify and advance a COVID-19 vaccine candidate.

24 Apr 2020

UAB to join international effort to test drugs for COVID-19

The University of Alabama at Birmingham will join an international effort coordinated by Scripps Research to test drugs for COVID-19.

24 Apr 2020

Sweden may reach ‘herd immunity’ in weeks as the country resists total lockdown

Herd immunity is a form of indirect protection against infectious diseases where a population develops sufficient immunity to a disease that that infection cannot spread within the group. A population can reach herd immunity if a large proportion has been exposed to the virus. Now, Sweden resisted total lockdown measures, unlike its neighboring countries, while experts believe herd immunity will be achieved in Stockholm within weeks.

24 Apr 2020

SARS News and Research

Early Heparin therapy improves hypoxia in COVID-19 patients

Misinformation on COVID-19 is tied to media usage

UCLA scientists receive awards to pursue treatments and vaccines for COVID-19

New antibody test to identify individuals infected with COVID-19 virus

Research Luxembourg launches Predi-COVID study

Resurgence of measles or polio outbreaks likely to happen, experts warn

Higher blood levels of NETs linked to more severe COVID-19 infection

USask's VIDO-Intervac receives $23 million to fast-track development of COVID-19 vaccine

Indiana State Department of Health and IU collaborate to study COVID-19 spread

Combination of two fabrics can effectively filter aerosol particles in face masks

Siemens Healthineers to expand SARS-CoV-2 testing to include a total antibody test to aid in the COVID-19 pandemic

Goblet cells in the human nasal passage may play key role in enabling COVID-19 infections

Researchers report promising Phase 1 results for first oral polio vaccine in 50 years

Biosero and Scripps Research Institute offer automated lab screening for COVID-19 drug therapy candidates

Scientists are developing synthetic COVID-19 antibody to treat sick patients

NEC leverages its AI prediction platforms to design blueprints for SARS-CoV-2 vaccines

AEM and Wiley offer full access to facilitate rapid dissemination of COVID-19 findings

UM researchers awarded $2.5 million to develop COVID-19 vaccine candidate

UAB to join international effort to test drugs for COVID-19

Sweden may reach ‘herd immunity’ in weeks as the country resists total lockdown

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News